Taking statins doesn't generally trigger muscle ache, new analysis suggests.
Prescribed for the prevention of heart problems, there was widespread concern the cholesterol-lowering medicine could regularly trigger muscle ache or weak spot.
Consultants recommend this ache can both trigger sufferers to cease taking the treatment or discourage them from taking it within the first place, which means they may miss out on the good thing about it reducing their threat of coronary heart assault or stroke.
A brand new examine checked out affected person information to analyse the danger of muscle ache attributable to statins in additional element than ever earlier than, and located that is low and doesn't outweigh the advantages of statin remedy.
These findings recommend that if a affected person on statins reviews muscle ache, then it ought to first be assumed that the signs aren't as a result of statin and are more than likely as a result of different causesProfessor Colin Baigent, College of Oxford
Professor Colin Baigent, director of the Medical Analysis Council Inhabitants Well being Analysis Unit on the College of Oxford, and joint lead creator of the examine, stated: “These findings recommend that if a affected person on statins reviews muscle ache, then it ought to first be assumed that the signs aren't as a result of statin and are more than likely as a result of different causes.
“Statin remedy ought to proceed till different potential causes have been explored.
“Moreover, in gentle of our evaluation, we imagine there's a must revise the knowledge within the treatment label for statins to make clear that the majority muscle ache skilled throughout statin remedy will not be as a result of statins.”
Statins are some of the generally prescription drugs within the UK, with as much as eight million individuals taking them.
The NHS web site lists muscle ache and some of the widespread negative effects.
However researchers say there must be a dialogue about how this message might be modified.
Prof Baigent stated: “Drug regulators world wide are involved to maintain sufferers secure.
“And up till now they’ve thought that doing that's finest served by having these warnings about the potential for muscle ache.
“What we’ve proven is definitely that that’s not one of the simplest ways to serve sufferers as a result of sufferers take that info, and the second they develop muscle ache, they believe the statin and that leads lots of them to cease the statin, which truly places them in hurt’s method.
“And so we’ve bought to try to change the stability of that, and work with the regulators to do a greater job of speaking the dangers.”
We hope that these outcomes will assist medical doctors and sufferers to make knowledgeable selectionsChristina Reith, Oxford Inhabitants Well being
An evaluation of knowledge from 155,000 sufferers from 23 trials of statin remedy discovered that when a affected person reviews muscle signs while taking a statin, there's a lower than 10% likelihood the ache is attributable to the drug.
It additionally means that the small elevated threat of muscle signs was largely noticed throughout the first yr of remedy.
After the primary yr there was no vital enhance within the threat of reporting muscle ache.
The researchers spotlight that the danger of muscle signs attributable to statins ought to be thought-about alongside the cardiovascular advantages of the remedy.
Given the findings, they're calling for a evaluation of the beneficial methods for managing muscle ache throughout statin use, and for the knowledge within the labels for the drug to be revised.
Dr Christina Reith, senior scientific analysis fellow at Oxford Inhabitants Well being and joint lead creator of the examine, stated: “We hope that these outcomes will assist medical doctors and sufferers to make knowledgeable selections about whether or not to begin or stay on statin remedy, making an allowance for its identified vital advantages in lowering the danger of heart problems.”
The examine discovered that, amongst 19 scientific trials which additionally concerned individuals being given a placebo, 27.1% of sufferers who got statins (16,835/62,028) reported muscle ache or weak spot, in comparison with 26.6% of those that got the placebo.
After the primary yr of remedy, there was no vital distinction in reviews of muscle ache or weak spot between these given statins and people given the placebo, the examine discovered.
The researchers stress that if sufferers expertise muscle signs, they need to inform their physician, and so they acknowledge that in very uncommon instances the drug may cause fairly critical muscle injury.
Professor Sir Nilesh Samani, medical director on the British Coronary heart Basis, which co-funded the examine stated: “This accumulation of knowledge from many scientific trials supplies a transparent image that whereas statins are related to a small enhance in threat of muscle pains or weak spot, they don't trigger nearly all of muscle ache signs generally related to them.
“It reinforces the proof that statins are secure, which ought to present reassurance to the many individuals taking, or contemplating taking, these lifesaving medicine which were confirmed to guard in opposition to coronary heart assaults and strokes.”
This examine is offered on the European Society of Cardiology Congress 2022, and printed in The Lancet.